Evidence map›Paper›PMID 41647884›Full record

ReviewThe Lancet regional health. Western Pacific2026

Examining the historical evolution of cancer policy in Australia: impact of key initiatives on equity and outcomes.

Helena Rodi, Anna Chapman, Rebecca J Bergin, Paul Grogan, Megan Varlow, Anna Boltong, Anna Ugalde, Skye Marshall

Abstract readReview
In one paragraph

Review in The Lancet regional health. Western Pacific, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Helena RodiCentre for Quality and Patient Safety Research, Institute for Health Transformation, School of Nursing and Midwifery, Faculty of Health, Deakin University, Victoria, Australia.
Anna ChapmanCentre for Quality and Patient Safety Research, Institute for Health Transformation, School of Nursing and Midwifery, Faculty of Health, Deakin University, Victoria, Australia.
Rebecca J BerginCentre for Quality and Patient Safety Research, Institute for Health Transformation, School of Nursing and Midwifery, Faculty of Health, Deakin University, Victoria, Australia.
Paul GroganSchool of Public Health, Sydney Medical School, University of Sydney, New South Wales, Australia.
Megan VarlowCancer Council Australia, Sydney, New South Wales, Australia.
Anna BoltongMonash University, Department of Nutrition, Dietetics and Food, School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing and Health Sciences, Victoria, Australia.
Anna UgaldeCentre for Quality and Patient Safety Research, Institute for Health Transformation, School of Nursing and Midwifery, Faculty of Health, Deakin University, Victoria, Australia.
Skye MarshallCentre for Quality and Patient Safety Research, Institute for Health Transformation, School of Nursing and Midwifery, Faculty of Health, Deakin University, Victoria, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Australia's cancer policy has progressed from fragmented, disease-specific initiatives in the 1960s-70s to coordinated national frameworks that aim to prioritise equity and patient-centred care. Early policies focused on treatment and prevention, with limited attention to disparities affecting different communities and population groups. This review aimed to examine the historical development of cancer policy in Australia and assess the impact of key initiatives on equity outcomes. A narrative review methodology was employed, drawing on policy documents, government reports, and peer-reviewed literature. Key milestones, systemic gaps, and strategies addressing disparities were identified and discussed. The review found a growing policy focus on addressing socioeconomic, geographic, and cultural barriers to care, reflected in initiatives such as the Australian Cancer Plan and Optimal Care Pathways. However, persistent challenges in implementation, resource allocation, and adherence monitoring limit progress. Strengthening monitoring systems and investing in prevention, early detection, high-quality care, and inclusive research remain critical to reducing the cancer burden and achieving equitable outcomes.

Indexed as

CancerCancer guidelinesCancer pathwaysCancer planCancer policyEquityHealth inequitiesHistoryNarrative reviewNeoplasmOptimal careOutcomes

Identifiers

PMID41647884
PMCPMC12869293

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.